New novel food approvals for 2 HMOs - meyer.science | München | Naturwissenschaftliche Beratung von Firmen der Lebensmittel‑, Kosmetik- und Pharmabranche

Food

Product Development - Health Claims – Crisis Management - Dossiers & Applications for Authorization

Consumer Products

Food Contact Materials – Migration Tests – Risk Assessment

Medicinal Products and Medical Devices

Borderline Issues – Authorization & Certification – Benefits Evaluation

Cosmetics

Composition of Substances - Labeling - Marketing – Safety Assessment

: 25.Oct.2023; Novel Food

In November, the EU Commission approved two more Human Milk Oligosaccharides (HMOs) as novel foods. These include:

3-Fucosyllactose produced by a derived strain of Escherichia coli K-12 DH1
6′-Sialyllactose sodium salt produced by a derived strain of Escherichia coli W (ATCC 9637)

For both authorizations, only the applicant shall be authorized to place the food on the market for a period of five years from the date of entry into force of the respective Regulation, unless a subsequent applicant obtains authorization for the novel food by consent of the applicant or without using the proprietary scientific data referred to in Article 3.

Both foods shall be labelled with the indication that it should not be consumed by

Children under three years of age
People who are already consuming other foods containing the ingredient in question on the same day

Further details, such as the specified food categories, maximum levels and specifications, can be found in Implementing Regulation (EU) 2023/2210 (3-Fucosyllactose) and Implementing Regulation (EU) 2023/2215 (6′-Sialyllactose sodium salt).

: 25.Oct.2023; Novel Food

In November, the EU Commission approved two more Human Milk Oligosaccharides (HMOs) as novel foods. These include:

3-Fucosyllactose produced by a derived strain of Escherichia coli K-12 DH1
6′-Sialyllactose sodium salt produced by a derived strain of Escherichia coli W (ATCC 9637)

For both authorizations, only the applicant shall be authorized to place the food on the market for a period of five years from the date of entry into force of the respective Regulation, unless a subsequent applicant obtains authorization for the novel food by consent of the applicant or without using the proprietary scientific data referred to in Article 3.

Both foods shall be labelled with the indication that it should not be consumed by

Children under three years of age
People who are already consuming other foods containing the ingredient in question on the same day

Further details, such as the specified food categories, maximum levels and specifications, can be found in Implementing Regulation (EU) 2023/2210 (3-Fucosyllactose) and Implementing Regulation (EU) 2023/2215 (6′-Sialyllactose sodium salt).

Größere Karte anzeigen

Top

We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Ok Decline

More information